FDA.reportPublic FDA data

Mounjaro 30 MG per 2.4 ML Pen Injector

RxCUI
2735290
RxNorm name
Mounjaro 30 MG per 2.4 ML Pen Injector
Display name
Mounjaro 30 MG per 2.4 ML Pen Injector
Full name
Mounjaro 30 MG per 2.4 ML Pen Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MounjaroTIRZEPATIDEEli Lilly and Companyd2d7da5d-ad07-4228-955f-cf7e355c8cc02026-04-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2735290

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d2d7da5d-ad07-4228-955f-cf7e355c8cc0mounjaro 7.5 MG per dose (30 MG in 2.4 ML) Pen Injector [PSN] · 2.4 ML tirzepatide 12.5 MG/ML Pen Injector [Mounjaro] [SBD] · Mounjaro 30 MG per 2.4 ML Pen Injector [SY]338These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422